EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tau pathology differs by sex in Alzheimer's disease in Down syndrome

Xu-Qiao Chen, Xinxin Zuo, William C Mobley

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.70838 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Xu-Qiao Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, School of Medicine, University of California San Diego, La Jolla, California, USA. Hauptthemen laut MEDLINE: Down Syndrome, Alzheimer Disease, tau Proteins, Brain. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DH Chen Foundation, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Alzheimer's disease (AD), the leading cause of dementia, is more common in females. Although sex differences in tau pathology have been reported in AD, findings remain inconsistent. Down syndrome (DS), caused by trisomy 21, is the most common genetic cause of AD (DS‐AD) and features tau pathology, but sex effects in DS‐AD remain unclear. METHODS We examined post mortem brain samples from individuals with DS‐AD, DS without AD, and a rare partial trisomy 21 (PT) case with only two amyloid precursor protein ( APP ) gene copies. PHF1 tau, total tau, and sarkosyl‐soluble and insoluble fractions were quantified by group and sex. RESULTS PHF1 tau was significantly elevated in DS‐AD, especially in females. Lower total tau in DS‐AD males explained the absence of sex differences after normalization. Sarkosyl‐insoluble tau was also higher in DS‐AD females. DS without AD, and the PT case showed minimal pathology. DISCUSSION These findings suggest sex‐specific tau dynamics in DS‐AD and support a role for APP dosage. Highlights Tau pathology is significantly elevated in individuals with DS‐AD, especially in females. Female DS‐AD brains show markedly higher PHF1 (S396/404) and sarkosyl‐insoluble tau levels compared to males. The observed sex difference in phosphorylated tau is driven by lower total tau in DS‐AD males. Minimal tau pathology is present in DS without AD and in a rare partial trisomy 21 case. These findings implicate APP gene dosage in tau pathology in DS‐AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Down SyndromeAlzheimer Diseasetau ProteinsBrainSex CharacteristicsHumansMaleFemaleMiddle AgedAgedAmyloid beta-Protein PrecursorAged, 80 and overAdultSex Factors

Stichwörter der Autor:innen

APPAlzheimer's diseaseDown syndromePHF1 tausarkosyl‐insolubletau

Substanzen

tau ProteinsAmyloid beta-Protein PrecursorMAPT protein, human

Autor:innen und Institutionen

  • Department of Neurosciences, School of Medicine, University of California San Diego, La Jolla, California, USA.

Förderung

  • DH Chen Foundation
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Chen, X. Q., Zuo, X., & Mobley, W. C. (2025). Tau pathology differs by sex in Alzheimer's disease in Down syndrome. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70838

Vancouver

Chen XQ, Zuo X, Mobley WC. Tau pathology differs by sex in Alzheimer's disease in Down syndrome. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70838

BibTeX
@article{Chen2025,
  author = {Chen, Xu-Qiao and Zuo, Xinxin and Mobley, William C},
  title = {Tau pathology differs by sex in Alzheimer's disease in Down syndrome},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.70838}
}
Kostenlos starten →